Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration

Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration

Background: The purpose of this study was to describe early changes in the morphology of pigment epithelium detachments (PED) after an intravitreal injection of Brolucizumab into eyes with macular neovascularization secondary to exudative age-related macular degeneration (e-AMD). Method: We included...

Full description

Bibliographic Details
Main Authors: Marco Rispoli, Chiara M. Eandi, Luca Di Antonio, Raphael Kilian, Andrea Montesel, Maria C. Savastano
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Biomedicines
Subjects:
age-related macular degeneration
innovative biotechnologies
Brolucizumab
exudative AMD
OCT angiography
personalized medicine
Online Access:https://www.mdpi.com/2227-9059/9/6/668

Internet

https://www.mdpi.com/2227-9059/9/6/668

Similar Items